Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

GE HealthCare Technologies (GEHC) Free Cash Flow (2022 - 2025)

Historic Free Cash Flow for GE HealthCare Technologies (GEHC) over the last 4 years, with Q4 2025 value amounting to $916.0 million.

  • GE HealthCare Technologies' Free Cash Flow rose 1294.7% to $916.0 million in Q4 2025 from the same period last year, while for Dec 2025 it was $1.5 billion, marking a year-over-year decrease of 315.32%. This contributed to the annual value of $1.5 billion for FY2025, which is 315.32% down from last year.
  • As of Q4 2025, GE HealthCare Technologies' Free Cash Flow stood at $916.0 million, which was up 1294.7% from $483.0 million recorded in Q3 2025.
  • In the past 5 years, GE HealthCare Technologies' Free Cash Flow ranged from a high of $986.0 million in Q4 2022 and a low of -$183.0 million during Q2 2024
  • For the 4-year period, GE HealthCare Technologies' Free Cash Flow averaged around $412.3 million, with its median value being $425.5 million (2022).
  • In the last 5 years, GE HealthCare Technologies' Free Cash Flow crashed by 7564.1% in 2023 and then surged by 10437.16% in 2025.
  • Quarter analysis of 4 years shows GE HealthCare Technologies' Free Cash Flow stood at $986.0 million in 2022, then fell by 3.04% to $956.0 million in 2023, then fell by 15.17% to $811.0 million in 2024, then increased by 12.95% to $916.0 million in 2025.
  • Its Free Cash Flow stands at $916.0 million for Q4 2025, versus $483.0 million for Q3 2025 and $8.0 million for Q2 2025.